Literature DB >> 2965025

Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors.

G Maura1, E Roccatagliata, M Ulivi, M Raiteri.   

Abstract

The effects of serotonin (5-HT) on the release of endogenous glutamate (GLU) in rat cerebellum were investigated in slices depolarized with 35 mM K+. The Ca2+-dependent release of GLU was potently inhibited by 5-HT in a concentration-dependent way. Release was also inhibited by the 5-HT1 receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and by the 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI). The inhibition by 10 nM 5-HT was partly (35-40%) counteracted by the 5-HT2 receptor antagonist ketanserin but was fully blocked by the mixed 5-HT1/5-HT2 receptor antagonist methiothepin. The effect of 8-OH-DPAT was not affected by ketanserin but was totally antagonized by methiothepin, while the effect of DOI was entirely suppressed by ketanserin. Ketanserin or methiothepin themselves increased (by 23 and 55%, respectively, at 10 nM) the K+-evoked release of GLU. In conclusion the release of endogenous GLU in rat cerebellum can be inhibited by 5-HT through receptors of the 5-HT1 and 5-HT2 type. The enhancement of GLU release by ketanserin or methiothepin could suggest a tonic inhibition. The possible localization of the 5-HT receptors involved in the interaction with the GLU systems is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965025     DOI: 10.1016/0014-2999(88)90345-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Development of monoamine oxidase activity and monoamine effects on glutamate release in cerebellar neurons and astrocytes.

Authors:  L Hertz; L Peng; E Hertz; B H Juurlink; P H Yu
Journal:  Neurochem Res       Date:  1989-10       Impact factor: 3.996

2.  Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats.

Authors:  M Gariboldi; P Tutka; R Samanin; A Vezzani
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 3.  Treatment of cerebellar ataxia with 5-HT1A agonist.

Authors:  Asako Takei; Takeshi Hamada; Ichiro Yabe; Hidenao Sasaki
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

Review 4.  5-HT2 receptor antagonists and migraine therapy.

Authors:  E J Mylecharane
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

5.  Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label study.

Authors:  Asako Takei; Shinsuke Hamada; Sanae Homma; Keiko Hamada; Kunio Tashiro; Takeshi Hamada
Journal:  Cerebellum       Date:  2010-12       Impact factor: 3.847

6.  Fluoxetine (prozac) and serotonin act on excitatory synaptic transmission to suppress single layer 2/3 pyramidal neuron-triggered cell assemblies in the human prefrontal cortex.

Authors:  Gergely Komlósi; Gábor Molnár; Márton Rózsa; Szabolcs Oláh; Pál Barzó; Gábor Tamás
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

7.  Serotonin 1A receptor inhibits the status epilepticus induced by lithium-pilocarpine in rats.

Authors:  Yi Yang; Yi Guo; Yifang Kuang; Shan Wang; Yan Jiang; Yao Ding; Shuang Wang; Meiping Ding
Journal:  Neurosci Bull       Date:  2014-01-15       Impact factor: 5.203

8.  Serotonergic inhibition of the mossy fibre--granule cell glutamate transmission in rat cerebellar slices.

Authors:  S Thellung; A Barzizza; G Maura; M Raiteri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

9.  Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.

Authors:  G Maura; A Barzizza; S Folghera; M Raiteri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

10.  Context-dependent effects of a single administration of mirtazapine on the expression of methamphetamine-induced conditioned place preference.

Authors:  Robin M Voigt; T Celeste Napier
Journal:  Front Behav Neurosci       Date:  2012-01-13       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.